Total Funding
70
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
ALS is a developer of a sustained release drug delivery system designed for the local delivery of biologic and small molecule drugs.
Seth Yakatan: Founder & CEO
About the Company
ALS is a developer of a sustained release drug delivery system designed for the local delivery of biologic and small molecule drugs. The company's system is a sustained release drug delivery system that is designed to significantly enhance and improve the therapeutic characteristics of new and approved drugs, enabling medical practitioners to
improve vision and prevent blindness with the use of these therapeutic systems.
Anogen Life Sciences was founded in 2006 and is based in St. Petersburg, FL.
